These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27208871)

  • 1. Clinical prognostic factors in adults with astrocytoma: Historic cohort.
    Wegman-Ostrosky T; Reynoso-Noverón N; Mejía-Pérez SI; Sánchez-Correa TE; Alvarez-Gómez RM; Vidal-Millán S; Cacho-Díaz B; Sánchez-Corona J; Herrera-Montalvo LA; Corona-Vázquez T
    Clin Neurol Neurosurg; 2016 Jul; 146():116-22. PubMed ID: 27208871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic factors in astrocytic tumors: analysis by the Kaplan-Meier method and the Weibull log-linear model].
    Hirano H; Asakura T; Yokoyama S; Kadota K; Kasamo S; Okahara K; Hirakawa W; Niiro M; Nakamura K; Nakayama M; Yamasaki I
    No Shinkei Geka; 1996 Sep; 24(9):809-15. PubMed ID: 8827730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of prognostic factors on survival in patients with low grade glioma.
    Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
    Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.
    Johnson DR; Brown PD; Galanis E; Hammack JE
    J Neurooncol; 2012 May; 108(1):187-93. PubMed ID: 22367412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of preoperative depression and survival after resection of malignant brain astrocytoma.
    Gathinji M; McGirt MJ; Attenello FJ; Chaichana KL; Than K; Olivi A; Weingart JD; Brem H; Quinones-Hinojosa A
    Surg Neurol; 2009 Mar; 71(3):299-303, discussion 303. PubMed ID: 18786716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
    Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas.
    Bagley JH; Babu R; Friedman AH; Adamson C
    Neurosurg Focus; 2013 Feb; 34(2):E7. PubMed ID: 23373452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect.
    McGirt MJ; Bulsara KR; Cummings TJ; New KC; Little KM; Friedman HS; Friedman AH
    J Neurosurg; 2003 Jan; 98(1):14-20. PubMed ID: 12546347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
    Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.
    Strowd RE; Abuali I; Ye X; Lu Y; Grossman SA
    J Neurooncol; 2016 Mar; 127(1):165-71. PubMed ID: 26729269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and prognostic factors of anaplastic gliomas.
    Nuño M; Birch K; Mukherjee D; Sarmiento JM; Black KL; Patil CG
    Neurosurgery; 2013 Sep; 73(3):458-65; quiz 465. PubMed ID: 23719055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
    Murakami R; Sugahara T; Nakamura H; Hirai T; Kitajima M; Hayashida Y; Baba Y; Oya N; Kuratsu J; Yamashita Y
    Radiology; 2007 May; 243(2):493-9. PubMed ID: 17356177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Supra-tentorial low-grade astrocytomas in adults. Prognostic factors and therapeutic indications. Apropos of a series of 141 patients].
    Loiseau H; Bousquet P; Rivel J; Vital C; Kantor G; Rougier A; Dartigues JF; Cohadon F
    Neurochirurgie; 1995; 41(1):38-50. PubMed ID: 7651570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
    Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
    Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.